Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2000
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070035A1 Inhibitors for viral infection targeting integrase n-terminal region
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070025A1 Methods of using rnase p reaction mechanisms of action
11/23/2000WO2000070024A2 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
11/23/2000WO2000069915A2 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
11/23/2000WO2000069907A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000WO2000069906A1 Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
11/23/2000WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069898A2 Molecular interactions in allergy cells
11/23/2000WO2000069897A2 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/23/2000WO2000069896A2 Molecular interactions in haematopoietic cells
11/23/2000WO2000069463A1 Compositions and methods for treating cell proliferation disorders
11/23/2000WO2000069462A1 Human monoclonal antibody
11/23/2000WO2000069460A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
11/23/2000WO2000069459A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
11/23/2000WO2000069458A2 Adjuvant combinations for immunization composition and vaccines
11/23/2000WO2000069457A1 Protein a based binding domains with desirable activities
11/23/2000WO2000069456A2 Adjuvant combination formulations
11/23/2000WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000WO2000069454A1 Suppression of endogenous igfbp-2 to inhibit cancer
11/23/2000WO2000069255A1 Anti-inflammatory therapy for inflammatory mediated infection
11/23/2000WO2000046242A3 19 KILODALTON PROTEIN OF $i(HELICOBACTER PYLORI)
11/23/2000WO2000038706A3 Methods for treating cancer and for mediating chemotaxis of dendritic cells
11/23/2000WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof
11/23/2000WO2000037067A9 Sensitizing agents for the treatment of skin lesions
11/23/2000WO2000036124A3 Plant cell cycle genes and uses thereof
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000030681A9 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
11/23/2000WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000027430A3 Composition consisting of influenza virus surface proteins and dispensing device
11/23/2000WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd)
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000021983A3 Tuberculosis vaccine and diagnostic reagents based on antigens from the mycobacterium tuberculosis cell
11/23/2000WO2000016746A3 Immunogenic liposome compositions
11/23/2000WO2000015790A3 Leptin induced genes
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000012127A3 Dna cancer vaccine and methods for its use
11/23/2000WO1999065871A3 Thiolesters and uses thereof
11/23/2000DE10024788A1 Substance for increasing an immune response during vaccinations or for increasing the production of antibodies, comprises solid lipid particles of a specific size and charge
11/23/2000DE10002892A1 New immunodominant peptides from actin, useful for diagnosis and treatment of type I autoimmune hepatitis
11/23/2000CA2767116A1 Adjuvant combination formulations
11/23/2000CA2374085A1 Tumour treatment with anti-erbb2 antibodies
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374013A1 Protein a based binding domains with desirable activities
11/23/2000CA2373938A1 Compositions and methods for treating cell proliferation disorders
11/23/2000CA2373824A1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000CA2373815A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
11/23/2000CA2373616A1 Tm4sf receptors
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372549A1 Ox2 receptor homologs
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372198A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2372105A1 Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
11/23/2000CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
11/23/2000CA2369397A1 Combined approach to treatment of cancer with hcg vaccines
11/23/2000CA2368833A1 Molecules expressed in hippocampus
11/23/2000CA2368593A1 Anti-inflammatory therapy for inflammatory mediated infection
11/22/2000EP1053751A1 Compositions and methods for treating cell proliferation disorders
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053343A2 Targeting of genetic vaccine vectors
11/22/2000EP1053329A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
11/22/2000EP1053325A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053320A2 Human transport-associated molecules
11/22/2000EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines
11/22/2000EP1053307A1 Podocalyxin like sialomucins having selectin ligand activity
11/22/2000EP1053301A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
11/22/2000EP1053256A1 Antibodies to death receptor 4 (dr4) and uses thereof
11/22/2000EP1053254A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
11/22/2000EP1053251A1 The aiolos gene
11/22/2000EP1053021A1 Simplified method for removing free protein during preparation of protein-polysaccharide conjugates and vaccines using restricted-access media
11/22/2000EP1053018A2 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES
11/22/2000EP1053017A2 Vaccines comprising interleukin-12 and herpes simplex viral antigen
11/22/2000EP1053016A2 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
11/22/2000EP1053015A2 Pneumococcal and meningococcal vaccines formulated with interleukin-12
11/22/2000EP1053014A1 BIOLOGICALLY ACTIVE HEMAGGLUTININ FROM TYPE A $i(CLOSTRIDIUM BOTULINUM) AND METHODS OF USE
11/22/2000EP1053011A1 Mixed micellar pharmaceutical delivery system and method of preparation
11/22/2000EP1053010A1 Copolymer compositions for oral delivery
11/22/2000EP1053009A2 Use of heregulin as an epithelial cell growth factor
11/22/2000EP1053007A2 Methods and compositions for modulating leptin activity
11/22/2000EP1053006A1 Costimulatory blockade and mixed chimerism in transplantation
11/22/2000EP1052988A1 Methods and compositions for inactivating viruses
11/22/2000EP0827502B1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
11/22/2000CN1274387A HCVE mimotopes of hypervariable region 1 and uses
11/22/2000CN1058638C Extraction method of allergen of intracellular mycobacterium
11/21/2000US6150508 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/21/2000US6150407 In a tissue or organ by contacting with a compound of given formula such as methyl-3,5-diiodo-4-(4'-methoxyphenoxy)benzoate; reducing the level of tumor necrosis factor alpha
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150125 Flea protease proteins and uses thereof
11/21/2000US6150116 Transcription factor DP-1 antibody
1 ... 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 ... 1823